Home Intralink Spine

Intralink Spine

Intralink-Spine Clinical Research Resumes in Australia

Tom Hedman, Ph.D., Founder and Chief Science Officer of Intralink-Spine, Inc. “Our outstanding early data also indicates that 85% of these patients had good or excellent clinical results from the 2-week through 2-year post-treatment time-points." 

Intralink-Spine, Inc. Announces ISO-13485 Certification

The certification process included an on-site audit of ILS’s newly constructed GMP manufacturing facility in Lexington, KY.

Intralink-Spine Expands Clinical Studies in Australia

The company reports the Réjuve treatment has the potential to fill the gap between non-operative treatments and surgery.

Intralink-Spine, Inc. Announces Initiation of Clinical Trials in Australia for their Patented Device Réjuve™

3/5/19: According to Hawkins, “We believe the Réjuve medical device, which structurally reinforces the native intervertebral disc itself, is going to be a better treatment option for many patients with low back pain.

Intralink-Spine Expands Clinical Studies To Multiple Sites and Locations

3/27/18: Company has restructured for growth and to better position themselves for a successful CE submission.

New Data for Intralink-Spine’s Réjuve Treatment for Low Back Pain

“We’ve demonstrated the safety of this device, and it has performed as expected. The dramatic pain reduction...